Edgestream Partners L.P. Invests $1.38 Million in Omega Healthcare Investors, Inc. (NYSE:OHI)

Edgestream Partners L.P. bought a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 33,938 shares of the real estate investment trust’s stock, valued at approximately $1,381,000.

Other hedge funds have also recently bought and sold shares of the company. Allworth Financial LP raised its position in shares of Omega Healthcare Investors by 12.0% during the third quarter. Allworth Financial LP now owns 2,276 shares of the real estate investment trust’s stock valued at $93,000 after buying an additional 244 shares during the last quarter. Venturi Wealth Management LLC grew its position in Omega Healthcare Investors by 29.4% during the third quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock worth $51,000 after buying an additional 286 shares in the last quarter. Cutter & CO Brokerage Inc. raised its holdings in Omega Healthcare Investors by 3.7% in the 2nd quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock valued at $281,000 after acquiring an additional 290 shares in the last quarter. NCP Inc. lifted its position in shares of Omega Healthcare Investors by 10.3% in the 2nd quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock worth $113,000 after acquiring an additional 310 shares during the period. Finally, V Square Quantitative Management LLC grew its holdings in shares of Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after purchasing an additional 323 shares in the last quarter. 65.25% of the stock is owned by institutional investors.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently commented on OHI. Scotiabank raised their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. BMO Capital Markets raised their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, October 7th. Royal Bank of Canada upped their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research note on Monday, November 11th. Truist Financial raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective on the stock in a research note on Thursday, October 31st. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $40.00.

Omega Healthcare Investors Price Performance

Shares of OHI stock opened at $39.54 on Wednesday. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42. The stock has a market capitalization of $10.67 billion, a PE ratio of 29.07, a PEG ratio of 1.24 and a beta of 0.98. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock’s fifty day moving average is $40.56 and its 200-day moving average is $37.53.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.78%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s payout ratio is presently 197.06%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.